StockData
ELI LILLY & Co logo

ELI LILLY & Co

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1410.99−6.55 (-0.46%)

Close on Nov 2, 2026Market cap $1.33TP/E 45.8Yield 0.44%

Eli Lilly Neuroscience — Worldwide revenue [legacy total] by Quarter

Neuroscience — Worldwide revenue ($M) [legacy total] ($M)

QuarterlyAnnual

Eli Lilly Neuroscience — Worldwide revenue [legacy total]: $429M in Q2 2026, up 24.7% from a year earlier.

Latest, Q2 2026
429
Period ended Jun 30, 2026
Change on a year earlier
+24.7%
344 in Q2 2025
History
44 quarters
Since Q2 2012
Sources
39
Documents cited below

Where the Q2 2026 figure comes from

Source: Form 10-Q (filed 2026-08-05) ↗

Reported in Form 10-Q / 10-K Note 2.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedNeuroscience — Worldwide revenue ($M) [legacy total] ($M)Year on yearSource
Q2 2026Jun 30, 2026429+24.7%Form 10-Q (filed 2026-08-05) ↗
Q1 2026Mar 31, 2026382+40.4%Form 10-Q (filed 2026-04-30) ↗
Q3 2025Sep 30, 2025316-10.3%Form 10-Q (filed 2025-10-30) ↗
Q2 2025Jun 30, 2025344+1.3%Form 10-Q (filed 2026-08-05) ↗
Q1 2025Mar 31, 2025272-30.1%Form 10-Q (filed 2026-04-30) ↗
Q3 2024Sep 30, 2024352-80.1%Form 10-Q (filed 2025-10-30) ↗
Q2 2024Jun 30, 2024340-12.3%Form 10-Q (filed 2025-08-07) ↗
Q1 2024Mar 31, 2024389+7.9%Form 10-Q (filed 2025-05-01) ↗
Q3 2023Sep 30, 20231,768+373.8%Form 10-Q (filed 2024-10-30) ↗
Q2 2023Jun 30, 2023387-0.7%Form 10-Q (filed 2024-08-08) ↗
Q1 2023Mar 31, 2023361-9.4%Form 10-Q (filed 2024-04-30) ↗
Q3 2022Sep 30, 2022373-17.1%Form 10-Q (filed 2023-11-02) ↗
Q2 2022Jun 30, 2022390-23.9%Form 10-Q (filed 2023-08-08) ↗
Q1 2022Mar 31, 2022398-14.5%Form 10-Q (filed 2023-04-27) ↗
Q3 2021Sep 30, 2021450-4.4%Form 10-Q (filed 2022-11-01) ↗
Q2 2021Jun 30, 2021512+21.2%Form 10-Q (filed 2022-08-04) ↗

Cite this data

StockData. (2026). Eli Lilly Neuroscience — Worldwide revenue [legacy total] ($M), quarterly Q2 2012–Q2 2026 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/ta-neuroscience-ww-legacy

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.